Cardiol Therapeutics Inc. (NASDAQ: CRDL) Stock Information | RedChip

Cardiol Therapeutics Inc. (NASDAQ: CRDL)


$1.2900
+0.0100 ( -4.44% ) 0.0K

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Market Data


Open


$1.2900

Previous close


$1.2800

Volume


0.0K

Market cap


$104.45M

Day range


$1.3500 - $1.3500

52 week range


$0.8110 - $3.1200

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Nov 18, 2024
6-k Form 6-K 7 Nov 14, 2024
6-k Form 6-K 3 Oct 22, 2024
6-k Form 6-K 6 Oct 11, 2024
6-k Form 6-K 4 Oct 10, 2024
6-k Form 6-K 5 Oct 09, 2024
6-k Form 6-K 9 Oct 08, 2024
6-k Form 6-K 3 Sep 24, 2024
6-k Form 6-K 3 Sep 10, 2024
6-k Form 6-K 7 Aug 12, 2024

Latest News